Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adults With Overweight/Obesity and Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06897202
What this trial is testing

Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Who this might be right for
Obesity in DiabetesType 2 Diabetes Mellitus (T2DM)
Pfizer 133
Testing effectiveness (Phase 2)Looking for participantsNCT06700538
What this trial is testing

A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity
Arrowhead Pharmaceuticals 180
Large-scale testing (Phase 3)Study completedNCT00737347
What this trial is testing

Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

Who this might be right for
Type 2 DiabetesObesity
Northwestern University 39
Testing effectiveness (Phase 2)Study completedNCT05081921
What this trial is testing

Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases

Who this might be right for
Osteoarthritis of Knee
Jagiellonian University 192
Testing effectiveness (Phase 2)Looking for participantsNCT07783802
What this trial is testing

Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Who this might be right for
AtherosclerosisCardiovascular DiseaseObesity+3 more
Eli Lilly and Company 120
Not applicableStudy completedNCT07389122
What this trial is testing

Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight

Who this might be right for
Obesity & OverweightMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Type 2 Diabetes+1 more
University of Bologna 110
Not applicableStudy completedNCT03651622
What this trial is testing

ACT1ON Phase 2 (SMART Pilot) and Phase 3 (Efficacy Trial Development)

Who this might be right for
Diabetes Mellitus, Type 1Overweight and Obesity
University of North Carolina, Chapel Hill 68
Large-scale testing (Phase 3)Looking for participantsNCT07595549
What this trial is testing

Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Who this might be right for
ObesityOverweight and/or ObesityOverweight
Pfizer 954
Not applicableUnknownNCT06284785
What this trial is testing

The Effects of Bariatric Surgery on Kidney Oxygenation in Obese Adults With Type 2 Diabetes and Hyperfiltration

Who this might be right for
Kidney HypoxiaDiabetes Mellitus, Type 2
Amsterdam UMC, location VUmc 100
Not applicableStudy completedNCT05648383
What this trial is testing

Promote Health With Digital Tools Among Adults With Type 2 Diabetes/Prediabetes and/or Hypertension

Who this might be right for
Type 2 DiabetesPreDiabetesHypertension+1 more
Harokopio University 1,215
Large-scale testing (Phase 3)Study completedNCT05887271
What this trial is testing

A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction

Who this might be right for
Heart Failure With Preserved Ejection FractionHeart Failure, DiastolicDiabetes Mellitus, Type 2+2 more
University of Leicester 66
Not applicableEnrolling By InvitationNCT07736547
What this trial is testing

AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss

Who this might be right for
Overweight (Without Type 2 Diabetes) With Weight-related ComorbiditiesOverweight (BMI > 25)
Varol TUNALI 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07575438
What this trial is testing

Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults

Who this might be right for
Type 2 DiabetesPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Prediabetes / Type 2 Diabetes+2 more
May Faraj, PDt, PhD 84
Not applicableNot Yet RecruitingNCT07567378
What this trial is testing

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

Who this might be right for
Psoriatic ArthritisOsteoarthitisKnee+12 more
JULIO GRANADOS MONTIEL 30
Testing effectiveness (Phase 2)Looking for participantsNCT07215559
What this trial is testing

Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Who this might be right for
ObesityOverweightDiabetes Mellitus, Type 2
Eli Lilly and Company 200
Testing effectiveness (Phase 2)Looking for participantsNCT07282743
What this trial is testing

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Who this might be right for
Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited 285
Large-scale testing (Phase 3)Not Yet RecruitingNCT06616961
What this trial is testing

Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus

Who this might be right for
ObesityType 2 Diabetes Mellitus (T2DM)
Popular Medical College Hospital 480
Testing effectiveness (Phase 2)Study completedNCT06062069
What this trial is testing

CT-868 in Type 1 Diabetes Mellitus

Who this might be right for
OverweightObeseType 1 Diabetes Mellitus
Carmot Therapeutics, Inc. 111
Post-approval studies (Phase 4)Study completedNCT05786521
What this trial is testing

Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

Who this might be right for
AgingDiabetes Mellitus, Type 2PreDiabetes+1 more
The University of Texas Health Science Center at San Antonio 20
Large-scale testing (Phase 3)Looking for participantsNCT07743450
What this trial is testing

Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Who this might be right for
ObesityOverweightChronic Weight Management+1 more
Ascletis Pharma (China) Co., Limited 1,560
Next Page